Nuwellis Inc (NASDAQ:NUWE) shares are surging Thursday afternoon as traders react to new pediatric data tied to the company’s Aquadex ultrafiltration therapy.
Nuwellis stock is showing exceptional strength.
What's fueling NUWE momentum?
What Is Driving Nuwellis' Stock Surge?
Nuwellis said a new single-center retrospective study supporting an alternative anticoagulation strategy for Aquadex ultrafiltration therapy was accepted by Frontiers in Pediatrics, highlighting epoprostenol as a potential option for keeping circuits open without adding bleeding risk or requiring intensive metabolic monitoring.
